Darko Vlahović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Darko Vlahović has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Dalibor Karlović
2 shared publications- Dalibor Karlović
School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia
2 shared publications - Vjekoslav Peitl
School of Medicine, Catholic University of Croatia, 10000 Zagreb, Croatia
2 shared publications Ana Matošić
Clinical Department of Psychiatry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia
1 shared publicationDaniela Vojnović
Clinical Department of Psychiatry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia
1 shared publicationDin Duraković
Clinical Department of Psychiatry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 15 September 2025
- Published by University of Zagreb School of Dental Medicine in Acta Stomatologica Croatica
- Vol. 59 (3) , 276-289
The Impact of ADHD Symptoms on Children’s Oral Health
This study aimed to evaluate the relationship between attention-deficit/hyperactivity disorder (ADHD) symptoms and various oral health outcomes in children, including dental trauma, plaque accumulation, gingivitis, endodontic treatment, and molar incisor hypomineralization (MIH). Eighty children (42 boys and 38 girls) aged 3 to 17 years participated in the study. Caregivers completed a standardized ADHD diagnostic tool (ADHDT) assessing inattention, hyperactivity, and impulsivity. Each child underwent a comprehensive oral examination to assess the presence of plaque, gingivitis, dental trauma, endodontically treated teeth, and MIH. No statistically significant associations were observed between ADHD symptoms and the presence of plaque, gingivitis, endodontic treatment, or MIH. However, a significant association was found between higher hyperactivity and impulsivity scores and increased incidence of dental trauma. Inattention symptoms did not demonstrate a significant relationship with any of the oral health indicators. Children exhibiting higher levels of hyperactivity and impulsivity may be at increased risk for dental trauma. These findings highlight the importance of integrating behavioral assessments into pediatric dental care to better identify and manage children who may be more vulnerable to oral injuries.
- 15 September 2025
- Published by University of Zagreb School of Dental Medicine in Acta Stomatologica Croatica
- Vol. 59 (3) , 276-289
Open AccessThe Impact of ADHD Symptoms on Children’s Oral Health
This study aimed to evaluate the relationship between attention-deficit/hyperactivity disorder (ADHD) symptoms and various oral health outcomes in children, including dental trauma, plaque accumulation, gingivitis, endodontic treatment, and molar incisor hypomineralization (MIH). Eighty children (42 boys and 38 girls) aged 3 to 17 years participated in the study. Caregivers completed a standardized ADHD diagnostic tool (ADHDT) assessing inattention, hyperactivity, and impulsivity. Each child underwent a comprehensive oral examination to assess the presence of plaque, gingivitis, dental trauma, endodontically treated teeth, and MIH. No statistically significant associations were observed between ADHD symptoms and the presence of plaque, gingivitis, endodontic treatment, or MIH. However, a significant association was found between higher hyperactivity and impulsivity scores and increased incidence of dental trauma. Inattention symptoms did not demonstrate a significant relationship with any of the oral health indicators. Children exhibiting higher levels of hyperactivity and impulsivity may be at increased risk for dental trauma. These findings highlight the importance of integrating behavioral assessments into pediatric dental care to better identify and manage children who may be more vulnerable to oral injuries.
- 26 August 2025
- Published by S. Karger AG in Neuropsychobiology
- Vol. 84 (4) , 219-230
Rethinking Lithium Monitoring: Insights from a Comparative Analysis of Saliva, Plasma, and Erythrocytes
Introduction: Lithium carbonate is a valuable and effective medication for treating and preventing mood disorders, especially bipolar disorder. Its narrow therapeutic window necessitates regular blood lithium monitoring. Existing literature does not conclusively support the reliability of salivary or erythrocyte lithium measurements. This study aimed to evaluate the predictive relationships between lithium concentrations in saliva, plasma, and erythrocytes at multiple time points during the day in patients receiving lithium carbonate treatment. The goal was to assess the temporal dynamics and relative utility of these biological matrices for therapeutic monitoring, while also considering the potential clinical advantages of noninvasive sampling methods. Methods: Subjects were recruited from patients undergoing treatment at the Clinical Department of Psychiatry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia, during the period between August 2024 and December 2024. We measured lithium levels in saliva, erythrocytes, and plasma of n = 77 participants with bipolar disorder or other psychiatric conditions at six time points during the day. A spectrophotometric method was used to determine lithium concentration. Results: Regression analyses demonstrated that erythrocyte lithium concentration was the most consistent and robust predictor of plasma levels across most time points. Salivary lithium showed weaker and more variable performance, but was significantly associated with plasma levels at selected time points in univariate models. The strongest overall model fit in the multiple linear regression analysis was observed at 3:00 PM (r2 = 0.665, p < 0.01), primarily driven by erythrocyte lithium. Conclusion: These findings support the use of erythrocyte lithium as a reliable and robust biomarker for estimating plasma levels, particularly in complex clinical scenarios where intracellular lithium may better reflect treatment response or toxicity. While salivary lithium demonstrated weaker and more time-dependent predictive accuracy, it still holds conditional clinical value as a noninvasive alternative – particularly in outpatient, emergency, or resource-limited settings where individualized or more accessible monitoring may be beneficial.
- 26 August 2025
- Published by S. Karger AG in Neuropsychobiology
- Vol. 84 (4) , 219-230
Rethinking Lithium Monitoring: Insights from a Comparative Analysis of Saliva, Plasma, and Erythrocytes
Introduction: Lithium carbonate is a valuable and effective medication for treating and preventing mood disorders, especially bipolar disorder. Its narrow therapeutic window necessitates regular blood lithium monitoring. Existing literature does not conclusively support the reliability of salivary or erythrocyte lithium measurements. This study aimed to evaluate the predictive relationships between lithium concentrations in saliva, plasma, and erythrocytes at multiple time points during the day in patients receiving lithium carbonate treatment. The goal was to assess the temporal dynamics and relative utility of these biological matrices for therapeutic monitoring, while also considering the potential clinical advantages of noninvasive sampling methods. Methods: Subjects were recruited from patients undergoing treatment at the Clinical Department of Psychiatry, Sestre Milosrdnice University Hospital Center, Zagreb, Croatia, during the period between August 2024 and December 2024. We measured lithium levels in saliva, erythrocytes, and plasma of n = 77 participants with bipolar disorder or other psychiatric conditions at six time points during the day. A spectrophotometric method was used to determine lithium concentration. Results: Regression analyses demonstrated that erythrocyte lithium concentration was the most consistent and robust predictor of plasma levels across most time points. Salivary lithium showed weaker and more variable performance, but was significantly associated with plasma levels at selected time points in univariate models. The strongest overall model fit in the multiple linear regression analysis was observed at 3:00 PM (r2 = 0.665, p < 0.01), primarily driven by erythrocyte lithium. Conclusion: These findings support the use of erythrocyte lithium as a reliable and robust biomarker for estimating plasma levels, particularly in complex clinical scenarios where intracellular lithium may better reflect treatment response or toxicity. While salivary lithium demonstrated weaker and more time-dependent predictive accuracy, it still holds conditional clinical value as a noninvasive alternative – particularly in outpatient, emergency, or resource-limited settings where individualized or more accessible monitoring may be beneficial.
- 25 May 2021
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 40 (1) , 56-61
Changes in platelet serotonin concentration after four weeks of alcohol abstinence depending on the genotype of the serotonin transporter
Alcohol use disorder (AUD) is a psychiatric disorder characterized by excessive and uncontrolled drinking that causes distress and has damaging consequences for men and women of all ages. It is one of the four most disabling diseases and it affects approximately 14.6 million persons in Europe. Objective of this study is to investigate changes in platelet serotonin concentration after four weeks of alcohol abstinence in regards to the genotype of the serotonin transporter. A total of 154 patients with AUD were included in the study. Platelet serotonin concentrations were assessed by enzyme-linked immunosorbent assay. Genotype of serotonin transporter promoter polymorphism was determined by the polymerase chain reaction-based method. We did not establish a statistically significant main effect of serotonin transporter polymorphism on platelet serotonin concentration after four weeks of abstinence. Aforementioned finding is in line with previous research suggesting a complex relationship between serotonin transporter gene and platelet serotonin levels, and congruent with the well-established genotype interaction with numerous other factors, such as sex, ethnicity, education level, and stressful life events.
- 25 May 2021
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 40 (1) , 56-61
Changes in platelet serotonin concentration after four weeks of alcohol abstinence depending on the genotype of the serotonin transporter
Alcohol use disorder (AUD) is a psychiatric disorder characterized by excessive and uncontrolled drinking that causes distress and has damaging consequences for men and women of all ages. It is one of the four most disabling diseases and it affects approximately 14.6 million persons in Europe. Objective of this study is to investigate changes in platelet serotonin concentration after four weeks of alcohol abstinence in regards to the genotype of the serotonin transporter. A total of 154 patients with AUD were included in the study. Platelet serotonin concentrations were assessed by enzyme-linked immunosorbent assay. Genotype of serotonin transporter promoter polymorphism was determined by the polymerase chain reaction-based method. We did not establish a statistically significant main effect of serotonin transporter polymorphism on platelet serotonin concentration after four weeks of abstinence. Aforementioned finding is in line with previous research suggesting a complex relationship between serotonin transporter gene and platelet serotonin levels, and congruent with the well-established genotype interaction with numerous other factors, such as sex, ethnicity, education level, and stressful life events.
- Open Access
- 1 January 2020
- Published by Sestre Milosrdnice University Hospital Center (KBC Sestre milosrdnice) in Acta Clinica Croatica
- Vol. 59. (4.) , 771-775
The Enigma of Lewy Body Dementia: a Case Report
Lewy body dementia is a progressive neurodegenerative disease and is considered to be the second most common cause of dementia in the elderly. Because of the complexity of clinical presentation, it is often misdiagnosed and mistaken for...
- 1 January 2020
- Published by Sestre Milosrdnice University Hospital Center (KBC Sestre milosrdnice) in Acta Clinica Croatica
- Vol. 59. (4.) , 771-775
Open AccessThe Enigma of Lewy Body Dementia: a Case Report
Lewy body dementia is a progressive neurodegenerative disease and is considered to be the second most common cause of dementia in the elderly. Because of the complexity of clinical presentation, it is often misdiagnosed and mistaken for...